124 related articles for article (PubMed ID: 6350771)
1. Recent studies of antileprosy drugs.
Shepard CC; Van Landingham RM; Walker LL
Lepr Rev; 1983 Jun; Spec No():23-30. PubMed ID: 6350771
[No Abstract] [Full Text] [Related]
2. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
3. Prothionamide and prothionamide-S-oxide in experimental leprosy.
Matsuo Y; Tatsukawa H; Murray JF; Peters JH
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):302-6. PubMed ID: 6459296
[No Abstract] [Full Text] [Related]
4. A series of new antileprosy compounds derived from serotonin.
Mester de Parajd L; Rees RJ; Ambrose EJ; Mester de Parajd M
Acta Leprol; 1985; 3(1):21-8. PubMed ID: 3927649
[No Abstract] [Full Text] [Related]
5. An experimental study of the antileprosy activity of a series of thioamides in the mouse.
Shepard CC; Jenner PJ; Ellard GA; Lancaster RD
Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):587-94. PubMed ID: 3910748
[TBL] [Abstract][Full Text] [Related]
6. Limited in vitro multiplication of Mycobacterium leprae: application to screening potential antileprosy compounds.
Dhople AM; Green KJ
Lepr Rev; 1986; 57 Suppl 3():149-62. PubMed ID: 3553808
[No Abstract] [Full Text] [Related]
7. Recent trends in chemotherapy of leprosy.
Parikh DA; Maniar JK; Parikh AC; Ganapati R
J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
[No Abstract] [Full Text] [Related]
8. Study of antileprosy activities of some dialkyldithiocarbamate derivatives.
Urlyapova NG; Yushchenko AA; Daudova AD; Makarov VA
Bull Exp Biol Med; 2007 Mar; 143(3):356-8. PubMed ID: 18225763
[TBL] [Abstract][Full Text] [Related]
9. Rapid in vitro metabolic screen for antileprosy compounds.
Franzblau SG; Hastings RC
Antimicrob Agents Chemother; 1987 May; 31(5):780-3. PubMed ID: 3300539
[TBL] [Abstract][Full Text] [Related]
10. The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice.
Colston MJ; Hilson GR; Banerjee DK
Lepr Rev; 1978 Mar; 49(1):7-15. PubMed ID: 347206
[No Abstract] [Full Text] [Related]
11. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
Innami S; Leguizamón OR; Alvarenga AE
Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
[No Abstract] [Full Text] [Related]
12. Strategies in the development of new drugs and drug combinations against leprosy, demonstrated on the example of folate and gyrase inhibitors.
Seydel JK; Rosenfeld M; Sathish M; Wiese M; Schaper KJ; Hachtel G; Haller R; Kansy M; Dhople AM
Lepr Rev; 1986; 57 Suppl 3():235-53. PubMed ID: 3033412
[No Abstract] [Full Text] [Related]
13. Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity.
Morrison NE; Collins FM
Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):180-6. PubMed ID: 7196888
[TBL] [Abstract][Full Text] [Related]
14. Application of ATP assay for in vitro drug screening testing against human derived M. leprae.
Katoch VM; Katoch K; Shivannavar CT; Sharma VD; Patil MA; Bharadwaj VP
Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179
[TBL] [Abstract][Full Text] [Related]
15. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.
Shepard CC
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):96-101. PubMed ID: 7042616
[No Abstract] [Full Text] [Related]
16. In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.
Ramasesh N; Krahenbuhl JL; Hastings RC
Antimicrob Agents Chemother; 1989 May; 33(5):657-62. PubMed ID: 2665640
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity.
Harris EB; Franzblau SG; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):588-91. PubMed ID: 3065422
[TBL] [Abstract][Full Text] [Related]
18. Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.
Franzblau SG
Antimicrob Agents Chemother; 1989 Dec; 33(12):2115-7. PubMed ID: 2694952
[TBL] [Abstract][Full Text] [Related]
19. Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents.
Franzblau SG; Biswas AN; Jenner P; Colston MJ
Lepr Rev; 1992 Jun; 63(2):125-33. PubMed ID: 1640779
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
Dhople AM
Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
